Naltrexone Treatment Centers in Arkansas

No. You can pay out of pocket, use Arkansas Medicaid (PASSE) if eligible, or qualify for sliding-scale rates at many Arkansas federally qualified health centers. Uninsured patients should still call naltrexone providers to ask about grant-funded slots and state-funded treatment vouchers.

For methadone, once SAMHSA take-home criteria are met, the monthly OTP fee covers both in-clinic and take-home doses. For buprenorphine, the clinic fee typically covers the 30-day prescription filled at a Arkansas pharmacy. For long-acting naltrexone (Vivitrol), the monthly dose is administered at the visit and included in that visit fee.

Yes. Pregnancy-related Arkansas Medicaid (PASSE) coverage includes MAT with no copays and priority access to Arkansas perinatal-MAT programs. Many Arkansas Medicaid (PASSE) plans also extend coverage for 12 months postpartum to protect the mother–infant dyad.

Call the number on the back of your insurance card and ask: (1) Is {provider name} in-network? (2) What is my mental-health/MAT deductible? (3) What is my copay for MAT visits? Write the reference number from the call for any dispute later.

For methadone, SAMHSA’s 2024 final rule allows OTPs in Arkansas to grant up to 28 days of take-home doses once clinical-stability criteria are met. For buprenorphine, 30-day prescriptions are standard and 90-day fills are permitted in many Arkansas plans. Long-acting naltrexone is a single monthly injection, so no take-home supply applies.

No. There is no legal or clinical cap on how long you can remain on naltrexone in Arkansas. Insurance must continue to cover MAT as long as the prescribing clinician documents medical necessity.

No. Arkansas employers have no right to require MAT disclosure. ADA protections and 42 CFR Part 2 confidentiality prevent providers from disclosing MAT status to employers. If you need FMLA for appointments, your HR can verify medical leave without knowing the diagnosis.

Yes. Records are protected by 42 CFR Part 2, which is stricter than HIPAA. Your employer, family, or law enforcement cannot access your records without your specific written consent or a narrowly tailored court order. Confidentiality applies from the first visit onward.

True allergic reactions to methadone, buprenorphine, or naltrexone are rare. Rash, swelling, or difficulty breathing after a dose should be treated as an emergency — call 911 or go to a Arkansas emergency department. The MAT team can switch medications after stabilization.

Naltrexone is typically not started during pregnancy due to limited safety data — methadone or buprenorphine are preferred. Patients already stable on naltrexone who become pregnant discuss continuing versus switching with their Arkansas MAT provider and obstetrician.

No. Attending 12-step programs is optional; SMART Recovery, Women for Sobriety, Refuge Recovery, and secular support groups are all acceptable alternatives. Arkansas MAT clinicians can help you match with a peer group aligned to your values.

Only if you disclose it. Your Arkansas clinic cannot inform your employer under 42 CFR Part 2. If you need FMLA leave, HR can verify the medical appointment without learning the diagnosis. Safety-sensitive roles may have specific DOT rules — consult an employment attorney.